Understanding Myeloproliferative Disorders

Clinical Trial MythBusters: What Is the Value of Diversity in Clinical Trials?

Is diversity, gender, age and ethnicity important in clinical trials? Mel Mann, a 20+ year CML survivor and a a highly respected leader in the field of clinical oncology weigh in.

Published:

What Indicates a Need for Another Bone Marrow Biopsy?

MPN expert Dr. Naveen Pemmaraju explains why your doctor may order a repeat bone marrow biopsy, important markers to look for and what results from this type of testing can reveal about disease progression. Watch now to find out more.

Published:

Mindfulness and MPNs: Maximizing Wellness Through Meditation, Diet and Exercise

In this Partners program, Andrew Schorr is joined by leading expert Dr. Ruben Mesa and two patients living with myeloproliferative neoplasm (MPNs). Julia, living with myelofibrosis (MF) for almost 10 years, and Samantha, living with polycythemia vera (PV) since age 26, discuss the ways in which they practice mindfulness in their daily life.

Published:

Will I Feel Like a Guinea Pig? A Four-Time Clinical Trial Participant Shares Her Experience

A common question patients have when considering a clinical trial is “will I be a guinea pig?” Meet Reina Weiner, a four-time clinical trial participant, as she shares her experience navigating the trial process, patient consent, safety, risks, family issues and more.

Published:

Are There Any New Treatment Options for MPN Patients With Anemia?

Tune in to hear renowned expert Dr. Naveen Pemmaraju give an update on anemia-targeted drugs in development and share how MPN patients can get involved in this important clinical research.

Published:

Can Low Clinical Trial Participation Inhibit Cancer Research and Innovation?

Lazarex chairman Dana Dornsife says that there’s a “48 percent failure rate of clinical trials, and it's not because the drug didn't work.” Why do some medicines never make it to market? Watch now to find out.

Published:

Finding the Right Match: Advice for Patients Who Qualify for Multiple Clinical Trials

Which clinical trial is the best choice for you? Watch now to hear Dr. Mike Thompson and patient advocate Jim Omel discuss factors to consider when weighing your options and share tips for patients trying to prioritize different trials.

Published:

Step One in Trial Participation: How Can Patients Learn About New Trials?

Myeloma survivor Reina Weiner and Lazarex chairman Dana Dornsife discuss ways patients can learn about new clinical trial opportunities and share resources to help alleviate the financial burden.

Published:

Should Polycythemia Vera Patients Avoid Vitamin K?

Watch now to hear MPN expert Dr. Naveen Pemmaraju explain the effect vitamin K has on iron levels, how it may interact with treatment and what patients should consider when it comes to diet.

Published:

Showing 9 of 333 programs
Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on November 7, 2013